» Articles » PMID: 2946876

Drug-induced Cutaneous Reactions. A Report from the Boston Collaborative Drug Surveillance Program on 15,438 Consecutive Inpatients, 1975 to 1982

Overview
Journal JAMA
Specialty General Medicine
Date 1986 Dec 26
PMID 2946876
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the data on 15,438 consecutive medical inpatients monitored by the Boston Collaborative Drug Surveillance Program from June 1975 to June 1982 to determine the rates of allergic cutaneous reactions to drugs introduced since 1975 and to confirm and extend findings from an earlier study of the preceding 22,227 patients. There were 358 reactions occurring in 347 patients, for an overall reaction rate among patients of 2.2%. Each patient received a mean of eight different drugs. Rashes were attributed to 51 drugs, and 75% of the allergic cutaneous reactions were attributed to antibiotics, blood products, and inhaled mucolytics. Amoxicillin (51.4 reactions per 1000 patients exposed), trimethoprim-sulfamethoxazole (33.8/1000), and ampicillin (33.2/1000) had the highest reaction rates. Drug-specific reaction rates ranged from zero to 51.4 per 1000 and were determined for 180 drugs or drug groups. These results provide physicians with quantitative data that will be helpful in clinical decision making when drug-induced exanthems, urticaria, or generalized pruritus occurs.

Citing Articles

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis.

Zhang S, Dong T, Xian J, Xiao X, Yuan J, Zeng T Front Pharmacol. 2025; 15():1519522.

PMID: 39834819 PMC: 11743256. DOI: 10.3389/fphar.2024.1519522.


How to Define and Manage Low-Risk Drug Allergy Labels.

Copaescu A, Li L, Blumenthal K, Trubiano J J Allergy Clin Immunol Pract. 2024; 12(5):1095-1106.

PMID: 38724164 PMC: 11493333. DOI: 10.1016/j.jaip.2024.03.021.


A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.

Sinha S, Kar C, Das S, Dutta A, De A Indian J Dermatol. 2024; 69(1):106.

PMID: 38572036 PMC: 10986873. DOI: 10.4103/ijd.ijd_944_20.


Evaluation of severe adverse cutaneous drug reactions in patients admitted to tertiary care center: A cross-sectional study.

Moshayedi M, Asilian A, Mokhtari F Health Sci Rep. 2024; 7(3):e1969.

PMID: 38486684 PMC: 10937814. DOI: 10.1002/hsr2.1969.


Case Report: Comprehensive Management of Pneumocystis Jiroveci Pneumonia (PJP) and Secondary Infections of Multiple-Drug Resistant and in a Kidney Transplant Recipient with Sulfonamide Allergies.

Zhu L, Xu H, Pu Y, Fu C, Pan Q, Zhao H Infect Drug Resist. 2023; 16:6185-6193.

PMID: 37724091 PMC: 10505427. DOI: 10.2147/IDR.S428890.